piracetam has been researched along with Thalassemia in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Thalassemia: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, FF | 1 |
| Zago, MA | 1 |
| Bottura, C | 1 |
1 other study available for piracetam and Thalassemia
| Article | Year |
|---|---|
Effects of piracetam and iodoacetamide on erythrocyte sickling.
Topics: Anemia, Sickle Cell; Animals; Antisickling Agents; Erythrocyte Aging; Erythrocytes, Abnormal; Humans | 1979 |